IRIS
LIGUORI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.804
AS - Asia 5.496
EU - Europa 4.227
Continente sconosciuto - Info sul continente non disponibili 1.020
SA - Sud America 794
AF - Africa 114
OC - Oceania 16
Totale 43.471
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.291
SG - Singapore 2.733
IT - Italia 1.458
CN - Cina 846
BR - Brasile 640
RU - Federazione Russa 532
HK - Hong Kong 423
BD - Bangladesh 422
VN - Vietnam 395
IE - Irlanda 367
DE - Germania 348
GB - Regno Unito 291
UA - Ucraina 262
FR - Francia 253
CA - Canada 248
KR - Corea 174
JP - Giappone 160
FI - Finlandia 151
NL - Olanda 118
SE - Svezia 113
PL - Polonia 81
IN - India 78
ID - Indonesia 61
AR - Argentina 56
CR - Costa Rica 51
ES - Italia 49
AT - Austria 44
MX - Messico 43
JM - Giamaica 39
ZA - Sudafrica 32
CO - Colombia 29
TR - Turchia 29
CZ - Repubblica Ceca 27
NI - Nicaragua 27
EG - Egitto 25
BE - Belgio 22
IQ - Iraq 22
HN - Honduras 19
SV - El Salvador 19
PH - Filippine 18
SA - Arabia Saudita 18
TT - Trinidad e Tobago 18
CL - Cile 16
DK - Danimarca 16
EC - Ecuador 16
PK - Pakistan 16
MY - Malesia 15
AU - Australia 14
CW - ???statistics.table.value.countryCode.CW??? 14
MA - Marocco 14
EE - Estonia 13
CH - Svizzera 12
RO - Romania 12
VE - Venezuela 12
GP - Guadalupe 11
AE - Emirati Arabi Uniti 10
GR - Grecia 10
LT - Lituania 10
PY - Paraguay 10
GT - Guatemala 9
KZ - Kazakistan 8
PR - Porto Rico 8
UZ - Uzbekistan 8
ET - Etiopia 7
EU - Europa 7
TN - Tunisia 7
AZ - Azerbaigian 6
DZ - Algeria 6
IL - Israele 6
KE - Kenya 6
PE - Perù 6
PT - Portogallo 6
BB - Barbados 5
JO - Giordania 5
QA - Qatar 5
AL - Albania 4
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
HU - Ungheria 4
LB - Libano 4
NG - Nigeria 4
NP - Nepal 4
SI - Slovenia 4
TH - Thailandia 4
TW - Taiwan 4
UY - Uruguay 4
AO - Angola 3
BG - Bulgaria 3
GE - Georgia 3
HR - Croazia 3
IR - Iran 3
KG - Kirghizistan 3
PA - Panama 3
SC - Seychelles 3
AG - Antigua e Barbuda 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
LK - Sri Lanka 2
MD - Moldavia 2
Totale 42.440
Salva come PNG Salva come JPEG
Città #
Wilmington 6.480
Houston 6.083
Woodbridge 5.585
Ashburn 1.742
Singapore 1.121
Fairfield 979
San Jose 907
Council Bluffs 668
Chandler 511
Seattle 427
Hong Kong 405
Los Angeles 383
Ann Arbor 376
Cambridge 375
Beijing 333
Dublin 318
Rome 310
New York 297
Santa Clara 270
Medford 235
Monte Vista 214
Milan 203
Jacksonville 196
The Dalles 158
Tokyo 132
Buffalo 123
Ho Chi Minh City 121
Lawrence 114
Dearborn 112
Lauterbourg 108
North Bergen 106
Hanoi 100
Dallas 94
Moscow 92
Denver 91
São Paulo 88
Helsinki 81
San Diego 74
Menlo Park 73
Colorado Springs 68
Toronto 66
Chicago 62
London 59
Boardman 56
Munich 55
Orem 55
Phoenix 55
Atlanta 50
Brooklyn 49
Montreal 49
Kraków 44
Norwalk 44
Zhengzhou 43
Miano 41
Jakarta 36
San José 36
Shanghai 34
Washington 33
Redwood City 32
Warsaw 32
Naples 31
Philadelphia 31
Seoul 31
Stockholm 31
Manchester 30
Nuremberg 30
Boston 29
Frankfurt am Main 27
Managua 27
Amsterdam 26
Carrboro 26
Miami 26
Bologna 24
San Francisco 24
Brno 23
Chennai 22
Johannesburg 22
Columbus 21
Brussels 20
Da Nang 20
Florence 20
Guangzhou 20
Redondo Beach 20
Durham 19
Kingston 19
Las Vegas 19
Salt Lake City 19
Istanbul 18
Vienna 18
Brasília 17
San Salvador 17
Cairo 16
Lappeenranta 16
Mexico City 16
Nanjing 16
Belo Horizonte 15
Daejeon 15
Kilburn 15
Rio de Janeiro 15
Verona 15
Totale 31.950
Salva come PNG Salva come JPEG
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 636
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 595
Paucisymptomatic Marchiafava-Bignami disease with relevant diffusion-weighted MRI lesions 570
Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs 546
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 534
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 519
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 508
Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment 501
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 493
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 492
Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea 488
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 485
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use 483
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 482
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 475
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 472
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 465
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 464
May a suspicious psychiatric disorder hide sporadic hemiplegic migraine? Genetic test as prompting factor for diagnosis 458
Restless legs syndrome and poliomyelitis: New evidences of an old observation? 458
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 457
Estrogen deficiency hampers the beneficial effect of continuous positive airway pressure therapy on serum vitamin D concentrations in postmenopausal women affected by obstructive sleep apnea 451
Pure ictal sensory seizures may represent a clinical manifestation of PLEDs 449
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD 449
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. 445
Fronto-central monomorphic theta activity as EEG pattern of ictal psychosis 443
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 443
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 439
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 438
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 438
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 437
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 436
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study 435
Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage 425
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 424
Catecholamine-based treatment in AD patients: expectations and delusions 424
CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? 421
Restless legs syndrome and post polio syndrome: a case-control study 415
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 415
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 406
May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy? 402
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function 402
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 402
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis 401
Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels 400
When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late-life depression 397
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 390
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report 381
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 381
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 375
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease 375
Obstructive sleep apnoea and bone health 369
Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity 366
Sleep-wake cycle in the Kennedy's disease: a controlled polysomnographic study and self-reported questionnaires 365
Low Serum 25(OH)D Levels in Parkinson ’s Disease; a Non Specific Marker of Neurodegeneration? 361
CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease 352
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 341
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 335
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 335
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 316
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 316
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 307
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 303
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 300
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 300
Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study 296
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 281
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 280
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 276
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 274
Prognostic Indicators and Outcomes of Hospitalised COVID-19 Patients with Neurological Disease: A Systematic Review and Individual Patient Data Meta-Analysis 274
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 267
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 257
Seasonality of restless legs syndrome: symptom variability in winter and summer times 251
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 224
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study 223
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 222
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 216
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 206
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 204
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 199
Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment 197
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 197
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 196
Laterality of Auditory Dysfunction in Parkinson's Disease 190
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 189
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 183
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 181
Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease 164
Biomarkers of cerebral glucose metabolism and neurodegeneration in Parkinson's disease: a cerebrospinal fluid-based study 160
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder 159
Is it time to consider obstructive sleep apnea syndrome a risk factor for Alzheimer's disease? 155
Increased noradrenaline as an additional cerebrospinal fluid biomarker in PSP-like parkinsonism 153
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 150
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 148
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 147
A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2 145
Band-Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates 142
Prevalence of sleep disorders in geriatrics: an exploratory study using sleep questionnaires 138
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients 136
Totale 34.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.143 0 0 0 33 26 64 229 41 69 104 94 483
2022/20231.438 179 119 49 151 131 324 128 103 127 27 57 43
2023/2024700 72 15 37 26 63 204 35 103 13 21 7 104
2024/20254.115 128 625 319 187 101 482 168 174 336 314 730 551
2025/20268.516 510 265 733 633 562 270 917 827 731 697 1.750 621
2026/20275.021 943 803 1.674 1.601 0 0 0 0 0 0 0 0
Totale 43.471